Special Issue "Vaccine Hesitancy and Acceptance across Vulnerable Subgroups: Challenges and Way Forward to Improve Public Health Globally"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines and Public Health".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 156

Special Issue Editors

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy
Interests: public health; global health; infectious diseases; vaccine-preventable diseases; tropical medicine, refugees and migrants health; health diplomacy; health policies
Principal Investigator/In-Charge Coordinator CSIR-CFTRI COVID-19 Testing Centre, Department of Biochemistry, CSIR- Central Food Technological Research Institute (CFTRI), Mysuru 570020, India
Interests: SARS-CoV-2; COVID-19; pathogenesis; food supplements; immune-boosting; antioxidant; anti-inflammation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccination is the most powerful public health intervention in history. However, debates around vaccination acceptance and hesitancy have become increasingly complex. The term ‘vaccine hesitancy’ has been defined as ‘…the delay in acceptance or refusal of vaccination despite availability of vaccination services’ and it is a major threat to global public health.

Understanding such a complex and variable phenomenon across contexts and countries requires knowledge and data on determinants. Unfortunately, evidence about the determinants of vaccine hesitancy and acceptance, particularly in vulnerable groups, including migrant, refugees, ethnic, gender and sexual minorities, is limited—and sometimes contradictory.

To fill these gaps, it is important to explore personal influences on vaccine hesitancy, as well as determinants of vaccine uptake, such as legal, linguistics, social, cultural barriers, discrimination or racism, which limit access to vaccines and are particularly relevant to vulnerable groups.
In this Special Issue, all article, reviews, commentaries providing new insights on drivers of under-immunization, vaccine hesitancy and acceptance, and shedding new light into current efforts to ensure high levels of global vaccine coverage are welcome.

Dr. Palmira Immordino
Dr. P. Veeranna Ravindra
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop